ATE552827T1 - Pharmazeutische tabletten mit einem relativ inaktiven segment - Google Patents

Pharmazeutische tabletten mit einem relativ inaktiven segment

Info

Publication number
ATE552827T1
ATE552827T1 AT05754171T AT05754171T ATE552827T1 AT E552827 T1 ATE552827 T1 AT E552827T1 AT 05754171 T AT05754171 T AT 05754171T AT 05754171 T AT05754171 T AT 05754171T AT E552827 T1 ATE552827 T1 AT E552827T1
Authority
AT
Austria
Prior art keywords
pharmaceutical tablets
relatively inactive
inactive segment
tablets
segment
Prior art date
Application number
AT05754171T
Other languages
English (en)
Inventor
Lawrence Solomon
Allan Kaplan
Original Assignee
Accu Break Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accu Break Technologies Inc filed Critical Accu Break Technologies Inc
Application granted granted Critical
Publication of ATE552827T1 publication Critical patent/ATE552827T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Glanulating (AREA)
AT05754171T 2004-05-21 2005-05-23 Pharmazeutische tabletten mit einem relativ inaktiven segment ATE552827T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57313404P 2004-05-21 2004-05-21
US57304204P 2004-05-21 2004-05-21
PCT/US2005/018639 WO2005112898A1 (en) 2004-05-21 2005-05-23 Pharmaceutical tablets having a relatively inactive segment

Publications (1)

Publication Number Publication Date
ATE552827T1 true ATE552827T1 (de) 2012-04-15

Family

ID=35456178

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05753917T ATE542523T1 (de) 2004-05-21 2005-05-23 Pharmazeutische tabletten mit zwei oder mehr einheitlichen segmenten
AT05754171T ATE552827T1 (de) 2004-05-21 2005-05-23 Pharmazeutische tabletten mit einem relativ inaktiven segment

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT05753917T ATE542523T1 (de) 2004-05-21 2005-05-23 Pharmazeutische tabletten mit zwei oder mehr einheitlichen segmenten

Country Status (9)

Country Link
US (6) US20080241239A1 (de)
EP (5) EP1755560B1 (de)
JP (5) JP2008500401A (de)
AT (2) ATE542523T1 (de)
AU (5) AU2005245025B2 (de)
CA (5) CA2564962C (de)
ES (4) ES2429540T3 (de)
IL (5) IL179432A0 (de)
WO (5) WO2005112870A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20120201883A1 (en) * 2004-05-21 2012-08-09 Accu-Break Technologies, Inc Antiviral compositons
AU2005245025B2 (en) * 2004-05-21 2010-06-03 Accu-Break Technologies, Inc. Pharmaceutical tablets comprising two or more unitary segments
US20080152595A1 (en) * 2004-11-24 2008-06-26 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of orally administered pharmaceutical products
JP5046501B2 (ja) * 2005-08-18 2012-10-10 帝人ファーマ株式会社 複数の薬物を分離して保持する錠剤
EP3205337A1 (de) * 2005-08-18 2017-08-16 Teijin Pharma Limited Formulierung, die eine genaue doseneinteilung aufweist
JP5123471B2 (ja) * 2005-08-18 2013-01-23 帝人ファーマ株式会社 用量調整が容易な製剤
WO2007021033A1 (ja) * 2005-08-18 2007-02-22 Teijin Pharma Limited 複数の薬物保持部位がある錠剤
US8158146B2 (en) 2005-09-28 2012-04-17 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
WO2007052592A1 (ja) * 2005-10-31 2007-05-10 Kowa Co., Ltd. 光安定性に優れた医薬製剤
NZ623674A (en) * 2005-12-09 2014-07-25 Vectus Biosystems Ltd Vip fragments and methods of use
BRPI0520830A2 (pt) * 2005-12-30 2009-05-19 Accu Break Technologies Inc forma de dosagem farmacêutica sólida, método de subdividir uma forma de dosagem farmacêutica sólida, método de administração de uma parte de uma subunidade ativa de uma forma de dosagem farmacêutica sólida, método de administração de um ingrediente farmacêutico ativo que está presente dentro de uma subunidade ativa de uma forma de dosagem farmacêutica sólida e método de produção de uma forma de dosagem farmacêutica sólida
WO2007098446A2 (en) * 2006-02-21 2007-08-30 Accu-Break Pharmaceuticals, Inc. Method for minimizing variation in dosage forms
US20070237815A1 (en) * 2006-04-06 2007-10-11 Lawrence Solomon Dosage forms and methods comprising amlodipine and chlorthalidone
US20080075772A1 (en) * 2006-04-13 2008-03-27 Lawrence Solomon Pharmaceutical compositions having novel scoring patterns and methods of using those compositions
CA2657437A1 (en) * 2006-06-19 2007-12-27 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
PE20080991A1 (es) 2006-06-27 2008-09-05 Novartis Ag Formas de dosificacion solidas de valsartan, amlodipina e hidroclorotiazida y metodo para elaborarlas
WO2008021875A2 (en) * 2006-08-08 2008-02-21 Accu-Break Technologies, Inc. Pharmaceutical tablets containing a plurality of active segments
US8741342B2 (en) * 2006-10-30 2014-06-03 Wockhardt Research Centre Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
CA2671092A1 (en) * 2006-11-30 2008-06-05 Accu-Break Technologies, Inc. Divisible osmotic dosage forms and methods of use
USD631537S1 (en) 2009-09-15 2011-01-25 Mcneil-Ppc, Inc. Oral dosage form
AU2010300641B2 (en) 2009-09-30 2016-03-17 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
US20110280936A1 (en) * 2010-05-17 2011-11-17 Aptapharma, Inc. Self Breaking Tablets
EP2682110B1 (de) * 2011-03-03 2019-12-04 Takeda Pharmaceutical Company Limited Manteltablette und herstellungsverfahren dafür
MX366159B (es) 2012-11-30 2019-07-01 Acura Pharmaceuticals Inc Liberacion autorregulada de ingrediente farmaceutico activo.
WO2015145461A1 (en) 2014-03-26 2015-10-01 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
US9839212B2 (en) 2015-04-16 2017-12-12 Bio-Lab, Inc. Multicomponent and multilayer compacted tablets
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
JP6745670B2 (ja) * 2016-07-29 2020-08-26 芝浦メカトロニクス株式会社 錠剤印刷装置、錠剤及び錠剤製造方法
US20190060243A1 (en) * 2017-08-25 2019-02-28 MD Medical Research Article and method for a pharmaceutical agent
BR112020017422A2 (pt) * 2018-03-29 2020-12-22 Avion Pharmaceuticals , Llc Composição de dose fracionada de levodopa e uso
CN111407734A (zh) * 2019-01-05 2020-07-14 厦门赛诺邦格生物科技股份有限公司 一种阳痿早泄治疗药物的固体制剂
CN112917981A (zh) * 2020-12-28 2021-06-08 陕西兴盛新材料股份有限公司 一种采用力的转向增压的电极压制工艺

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128226A (en) * 1962-08-22 1964-04-07 Hoffmann La Roche Composition for relieving pain
US3336200A (en) 1963-05-28 1967-08-15 Warner Lambert Pharmaceutical Tablet structure
USD201497S (en) * 1964-09-28 1965-06-29 Warner Lambert Co Tablet
US3450252A (en) * 1968-04-17 1969-06-17 Richardson Merrell Inc Dispensing container
US3696091A (en) * 1970-06-03 1972-10-03 Boehringer Sohn Ingelheim Novel cardiac-active principles of the cardenolide glycoside class
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US3927194A (en) * 1972-12-06 1975-12-16 Ives Lab Inc Tablet formulation
US4258027A (en) * 1979-03-26 1981-03-24 Mead Johnson & Company Multi-fractionable tablet structure
US4215104A (en) 1979-03-26 1980-07-29 Mead Johnson & Company Multi-fractionable tablet structure
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
CH648754A5 (en) * 1979-08-16 1985-04-15 Ciba Geigy Ag Pharmaceutical slow release tablet
US4473192A (en) * 1982-01-22 1984-09-25 Hoefchst-Roussel Pharmaceuticals Incorporated Tablet breaking device
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
JPH069375B2 (ja) 1984-04-27 1994-02-02 株式会社東芝 中間調画情報の符号化伝送方式
US4824677A (en) * 1986-12-18 1989-04-25 The Unjohn Company Grooved tablet for fractional dosing of sustained release medication
US4905589A (en) * 1987-02-06 1990-03-06 Ackley E Michael Ink-jet system for marking pellet-shaped articles
ATE84963T1 (de) * 1987-12-17 1993-02-15 Upjohn Co Dreifach gekerbte arzneimitteltablette.
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
US5041430A (en) * 1989-09-18 1991-08-20 Du Pont Mereck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5061494A (en) * 1990-06-14 1991-10-29 The Upjohn Comany Tri-scored drug tablet
GB9107378D0 (en) 1991-04-08 1991-05-22 Ici Plc Olefin polymerisation
US5158728A (en) 1991-04-12 1992-10-27 Elizabeth-Hata International, Inc. Multi-layer medicinal tablet forming machine and method for using the same
US5118021A (en) * 1991-05-10 1992-06-02 American Medical Industries Pill splitter
JPH069375A (ja) * 1992-04-10 1994-01-18 Takeda Chem Ind Ltd 分割可能な連結錠剤
IT1255522B (it) 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
US6183778B1 (en) 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
JP3168582B2 (ja) * 1993-12-10 2001-05-21 藤沢薬品工業株式会社 解熱鎮痛配合剤
GB9401894D0 (en) * 1994-02-01 1994-03-30 Rhone Poulenc Rorer Ltd New compositions of matter
TW483763B (en) 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
US5756124A (en) * 1995-08-07 1998-05-26 Invamed, Inc. Multi-scored pharmaceutical tablets
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6919373B1 (en) * 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
GB9624563D0 (en) 1996-11-27 1997-01-15 Smithkline Beecham Plc Product
ATE277594T1 (de) * 1998-06-03 2004-10-15 Alza Corp Vorrichtungen um eine verlängerte medikamententherapie zu erreichen
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
DE19927688A1 (de) 1999-06-17 2000-12-21 Gruenenthal Gmbh Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
US6375956B1 (en) * 1999-07-22 2002-04-23 Drugtech Corporation Strip pack
JP2001187749A (ja) * 1999-10-18 2001-07-10 Tanabe Seiyaku Co Ltd 長期徐放性圧縮成型製剤およびその製造法
US7674480B2 (en) * 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
WO2002030392A2 (en) * 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6555581B1 (en) * 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
CN1606434A (zh) * 2001-12-19 2005-04-13 株式会社三和化学研究所 控制释放成型品
NZ534039A (en) * 2002-01-15 2006-08-31 Ucb Farchim S Formulations of pharmaceutical compositions for oral administration
US6946156B2 (en) * 2002-05-15 2005-09-20 Mcneil-Ppc, Inc. Process for enrobing a core
US20050215625A9 (en) * 2003-01-08 2005-09-29 Nesselroad James M Iii Combination therapy for anticoagulation
BRPI0410555A (pt) * 2003-06-06 2006-06-20 Takeda Pharmaceutical preparação sólida
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
TWI366110B (en) * 2004-02-26 2012-06-11 Ibm Providing a portion of an electronic mail message based upon a transfer rate, a message size, and a file format
US7329418B2 (en) * 2004-05-21 2008-02-12 Accu Break Technologies, Inc. Pharmaceutical tablets having height greater than width
US7713547B2 (en) * 2004-05-21 2010-05-11 Accu-Break Pharmaceuticals, Inc. Method of administering a partial dose of a segmented pharmaceutical tablet
US7622137B2 (en) * 2004-05-21 2009-11-24 Accu-Break Technologies, Inc. Dosage forms contained within a capsule or sachet
US7318935B2 (en) * 2004-05-21 2008-01-15 Accu-Break Technologies, Inc. Pharmaceutical tablets with active and inactive segments
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
AU2005245025B2 (en) * 2004-05-21 2010-06-03 Accu-Break Technologies, Inc. Pharmaceutical tablets comprising two or more unitary segments

Also Published As

Publication number Publication date
JP2008500404A (ja) 2008-01-10
US20080199521A1 (en) 2008-08-21
CA2566310C (en) 2014-05-13
US20080233189A1 (en) 2008-09-25
AU2005292670A1 (en) 2006-04-13
IL179433A0 (en) 2007-05-15
EP1755564A2 (de) 2007-02-28
EP1755564B1 (de) 2013-10-16
EP1746979A4 (de) 2007-07-04
JP2008500403A (ja) 2008-01-10
WO2006038916A2 (en) 2006-04-13
ATE542523T1 (de) 2012-02-15
AU2005245028A1 (en) 2005-12-01
WO2005112900A1 (en) 2005-12-01
ES2379967T3 (es) 2012-05-07
AU2005245026B2 (en) 2010-07-01
ES2385832T3 (es) 2012-08-01
WO2006038916A3 (en) 2006-10-12
EP1750647A4 (de) 2007-07-04
EP1755563A1 (de) 2007-02-28
IL179432A0 (en) 2007-05-15
CA2565029A1 (en) 2005-12-01
CA2564961A1 (en) 2005-12-01
EP1750647B1 (de) 2014-11-19
CA2566310A1 (en) 2006-01-13
JP5395355B2 (ja) 2014-01-22
AU2005245027A1 (en) 2005-12-01
AU2005245027B2 (en) 2011-05-19
AU2005245025A1 (en) 2005-12-01
EP1755560A4 (de) 2007-07-04
JP5008565B2 (ja) 2012-08-22
JP2008500402A (ja) 2008-01-10
US7988996B2 (en) 2011-08-02
AU2005245025B2 (en) 2010-06-03
CA2564961C (en) 2014-07-15
EP1746979A2 (de) 2007-01-31
WO2005112897A3 (en) 2006-09-21
CA2564960A1 (en) 2005-12-01
EP1755563B1 (de) 2012-01-25
IL179431A0 (en) 2007-05-15
CA2565029C (en) 2013-09-03
US20080003285A1 (en) 2008-01-03
WO2005112898A1 (en) 2005-12-01
EP1755564A4 (de) 2007-07-04
ES2429540T3 (es) 2013-11-15
US20080241239A1 (en) 2008-10-02
EP1746979B1 (de) 2013-09-11
US20090130207A1 (en) 2009-05-21
WO2005112870A1 (en) 2005-12-01
AU2005292670B2 (en) 2011-02-03
US7879352B2 (en) 2011-02-01
EP1750647A1 (de) 2007-02-14
EP1755560A1 (de) 2007-02-28
IL179429A0 (en) 2007-05-15
US20070134321A1 (en) 2007-06-14
CA2564962C (en) 2013-08-06
JP2008500401A (ja) 2008-01-10
JP2008500400A (ja) 2008-01-10
EP1755560B1 (de) 2012-04-11
EP1755563A4 (de) 2007-07-04
US8034380B2 (en) 2011-10-11
IL179430A0 (en) 2007-05-15
WO2005112897A2 (en) 2005-12-01
CA2564962A1 (en) 2005-12-01
AU2005245028B2 (en) 2010-12-09
US8158148B2 (en) 2012-04-17
AU2005245026A1 (en) 2005-12-01
ES2439572T3 (es) 2014-01-23

Similar Documents

Publication Publication Date Title
ATE552827T1 (de) Pharmazeutische tabletten mit einem relativ inaktiven segment
FI5842U1 (fi) Farmaseuttinen annosmuoto, joka käsittää suuren määrän lääkerakeita
AR048331A1 (es) Sistema de administracion de farmacos con retencion gastrica
EP1849470A4 (de) Arzneistoff gegen krebs mit alpha, alpha, alpha-trifluorthymidin und thymidin-phosphorylase-inhibitor
IS2759B (is) CGRP-viðtakamótlyf, lyfjaefnablanda og notkun á efnablöndunum til framleiðslu á lyfi
EA200501586A1 (ru) Фармацевтические продукты
JO3323B1 (ar) صور جرعة صيدلانية
EP1919288A4 (de) Famotidin- und ibuprofenhaltige arzneimittel und ihre verabreichung
ZA200701059B (en) Pharmaceutical dosage forms comprising a low-solubllity drug and a polymer
IL181150A0 (en) Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle
DE602005021475D1 (de) Magenresistente pharmazeutische dosierform mit n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutaminsäure (lk-423)
EP1750693A4 (de) Okuloselektive arzneimittel und prodrugs
EP1900368A4 (de) Tablette mit einem kaum löslichen wirkstoff
ATE438575T1 (de) Spender
ATE437857T1 (de) Neuartige pyridinylaminalkylen- und pyridinyloxalkylen-cyclopropanamine, herstellungsverfahren dafür und pharmazeutische zusammensetzungen damit
DK1750765T3 (da) Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel
ZA200506992B (en) Fibrate tablet and method for the production thereof
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar
NL1023797A1 (nl) Farmaceutische doseringsvorm die zwangerschapsvriendelijke onderscheidingstekens draagt.
CR8948A (es) Composicion farmaceutica
ZA200610683B (en) Pharmaceutical tablets having a relatively inactive segment
ATE479428T1 (de) Olanzapin enthaltende pharmazeutische zusammensetzung
GT200500251A (es) Composicion farmaceutica
ATE481377T1 (de) Hydroxyphenol-derivate, herstellungsverfahren dafür, pharmazeutische zusammensetzungen damit und therapeutische verwendung
CL2003002385A1 (es) Tableta farmaceutica que comprende 0,1 a 10% de tibolona provista con un revestimiento.